Company: KAVL
Filing Date: 2025-02-10
Form Type: 10-K
Source: 0001731122-25-000185
Chunk: 183

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-02-10
Form: 10-K
Item: Item 1A
Chunk 183
---
 are not a party to the legal or regulatory proceedings involving Bidi
described in Item 1 – Business – FDA PMTA and MDO Determinations, Related Court Actions and the Impact on Our Business, the
outcome of those or related proceedings could have a material adverse impact on our ability to operate our business given our reliance
on Bidi.

Item 4. Mine Safety Disclosures.

Not applicable.

35

PART II

Item 5. Market for Registrant’s Common Equity,
Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

On July 20, 2021, our Common Stock began trading on
the Nasdaq Capital Market under the trading symbol “KAVL.” On February 6, 2025, the last reported sales price of our Common
Stock was $1.35. 

Holders

As of February 6,
2025, we had approximately 287 record holders of our Common
Stock.

Dividends

We do not currently pay dividends on our shares of
Common Stock and have no intention of paying dividends on shares of our Common Stock for the foreseeable future.

Recent Sales of Unregistered Securities; Uses of Proceeds from Registered
Securities

Common Stock 

Our
                                            authorized Common Stock consists of 1,000,000,000 shares with a par value
of $0.001 per share. There were 8,517,302 shares of Common Stock issued and outstanding as of October 31, 2024 as compared to 2,793,386
shares of the Common Stock issued and outstanding as of October 31, 2023.

During the year ended October 31, 2024, the Company
issued 1,400,144 shares of Common stock to Bidi Vapor LLC pursuant to a debt exchange agreement dated October 25, 2024. Pursuant to such
issuance, Bidi Vapor LLC and the Company agreed that the outstanding account payable of $1,275,000 would be repaid in full and extinguished.

During the year ended October 31, 2024, the Company
issued 1,746,500 shares of common stock in connection with the June 2024 Public Offering.

During the year ended October 31, 2024, the Company
issued 2,174,456 shares of common stock from exercises of pre-funded warrants.

During the year ended October 31, 2024, the Company
issued 52,949 shares